The Assistance Fund Opens New Program for Bronchiectasis

Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Bronchiectasis

ORLANDO, FL / ACCESS Newswire / August 18, 2025 / The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new copay assistance program for people living with bronchiectasis. The program is designed to help eligible individuals pay for their out-of-pocket medical costs for treatment, such as copays, coinsurance, and deductibles.

Bronchiectasis is a chronic lung disease where people are unable to properly clear mucus. People living with bronchiectasis experience a buildup of mucus in the lungs that can cause infections and coughing fits. Nearly half a million Americans currently live with bronchiectasis. [1]

“Living with bronchiectasis means more than managing a chronic lung condition-it involves unpredictable flare-ups, ongoing treatment, and the financial strain of affording those costs,” said Danielle Vizcaino, President and CEO of The Assistance Fund. “Thanks to our generous donors, our Bronchiectasis Copay Assistance Program helps ease that burden, allowing people to focus on their health rather than the next medical bill.”

To learn more or determine eligibility for financial support, visit tafcares.org or call (833) 426-2085 to speak with a Patient Advocate.

A list of all the disease programs available from The Assistance Fund can be found on the website tafcares.org.

About The Assistance Fund

The Assistance Fund (TAF) is an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses. The Assistance Fund currently manages nearly 100 disease programs, each of which covers all the FDA-approved medications that treat a specific disease named in the disease program. Since its founding in 2009, TAF has helped over 210,000 children and adults access the treatment they need to stay healthy or manage a life-changing disease. To learn more about The Assistance Fund, or for information on how to donate, please visit tafcares.org.

Media Contact

Margaret Figley
Senior Director of Communications
margaret.figley@tafcares.org

[1] Cleveland Clinic, “Bronchiectasis,” https://my.clevelandclinic.org/health/diseases/21144-bronchiectasis, accessed August 2025.

SOURCE: The Assistance Fund (TAF)

View the original press release on ACCESS Newswire

Staff

Recent Posts

Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options

Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…

7 hours ago

Direct Meds GLP-1 Medications Platform Maintains LegitScript Certification as New Year Weight Loss Interest Peaks Amid Compounding Regulatory Shifts

Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage…

7 hours ago

Best Peptides for Boosting Growth Hormone: ReadyRx Lists Prescription Sermorelin in Injectable and Needle-Free Formats for 2026

Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable…

7 hours ago

Best Fat Burner For Men 2026: Effective Fat Burning Supplements For Men’s Belly Fat Launched By Wolfson Brands Ltd

Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements…

7 hours ago

MEDIROM Partners with World

Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex…

7 hours ago